• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Scrub typhus linked to high disease burden in rural India

byZhenyu LiandKiera Liblik
April 7, 2025
in Infectious Disease, Public Health
Reading Time: 2 mins read
Population-based risk factors and geographical trends identified for vitiligo
Share on FacebookShare on Twitter

1. In this cohort study, scrub typhus was a common cause of febrile illness in rural South India, with an incidence of 6.0 cases per 1000 person-years.

2. Asymptomatic infection was widespread, with a high seroconversion rate indicating significant underrecognized disease burden.

Evidence Rating Level: 2 (Good)

Study Rundown: Scrub typhus, caused by the mite-born bacteria Orientia tsutsugamushi, is a significant cause of undifferentiated fever across South and Southeast Asia. This population-based cohort study assessed the burden of scrub typhus in rural South India, identifying it as a significant cause of febrile illness. Many cases led to hospitalization, and severe complications were observed, particularly among older adults and individuals with diabetes. A high rate of asymptomatic infection indicated that scrub typhus is likely underrecognized in endemic areas. The study’s large sample size and systematic follow-up provided strong epidemiologic data, but potential underreporting due to COVID-19 restrictions and reliance on serologic testing were notable limitations. The study highlights that scrub typhus is a significant cause of febrile illness in endemic areas, often requiring hospitalization. Delayed diagnosis and a lack of awareness hinder treatment despite the availability of effective antibiotic options.

Click here to read the study in NEJM

In-Depth [prospective cohort]: This population-based cohort study was conducted over two years in rural Tamil Nadu, India, where scrub typhus is endemic. The study enrolled 32,279 participants, tracking febrile illnesses through regular household visits every six to eight weeks. Blood samples were collected for serological and molecular testing to confirm Orientia tsutsugamushi infections. Among the 4,474 blood samples collected, 328 met the criteria for scrub typhus diagnosis based on IgM ELISA positivity, qPCR detection, or eschar presence. Of these cases, 21.6% required hospitalization, with an incidence of 1.3 cases per 1000 person-years (95% Confidence Interval [CI], 1.0 to 1.7). Additionally, 8.8% of cases were classified as severe, occurring at a rate of 0.5 cases per 1000 person-years (CI, 0.4 to 0.8). The case fatality rate was 1.5%, with five confirmed deaths attributed to the infection. The study also included a serologic subcohort of 2128 participants to assess asymptomatic infections. The incidence of seroconversion was 81.2 per 1000 person-years (CI, 70.8 to 91.6), with older individuals showing higher seroprevalence and infection rates. While IgG positivity was associated with reduced severity of illness, it did not prevent reinfection, emphasizing the need for further preventive measures. Older individuals and women exhibited higher infection rates, though severity levels remained consistent across genders. Past infection did not provide full immunity, reinforcing the potential for reinfection. The findings underscore the necessity for increased surveillance, improved diagnostic efforts, and the development of preventative strategies.

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: epidemiologyinfectious diseaseOrientia tsutsugamushipublic healthscrub typhus
Previous Post

2 Minute Medicine Rewind April 7, 2025

Next Post

#VisualAbstract: Invitation to Fecal Immunochemical Test is Noninferior to Colonoscopy Screening in Colorectal Cancer Mortality

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

A landmark court ruling was associated with increased travel across state borders for abortion care

August 28, 2026
Next Post
#VisualAbstract: Invitation to Fecal Immunochemical Test is Noninferior to Colonoscopy Screening in Colorectal Cancer Mortality

#VisualAbstract: Invitation to Fecal Immunochemical Test is Noninferior to Colonoscopy Screening in Colorectal Cancer Mortality

Fluorophores enhance visualization for image-guided surgery [PreClinical]

Taletrectinib in ROS1 mutated Non–Small Cell Lung Cancer

American Academy of Pediatrics recommends standards for adverse event disclosures

Central sensitization syndrome may be associated with chronic autonomic concerns

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.